Navigation Links
Manitoba Ombudsman Warns Pharmacists

Pharmacists have been warned by the Manitoba Ombudsman that they should respect the desire of patients to remain anonymous, particularly while receiving emergency// contraception. A woman had already complained that embarrassing questions were asked by the pharmacists while she was buying the Levonorgestrel, also called the drug Plan B. The questions asked were with regard to the woman’s sexual relations. Such medicines do not require a prescription nor the personal health information of the patient, according to the ombudsman.

Identifying or recording the patient’s information should be done only with the consent of the patient, according to the authority. A similar notice has also been issued by the Manitoba Pharmaceutical Association. The pharmacist should also reveal the reason if he does not wish to supply the medicine asked for by the patient. Plan B, also known as the morning-after pill is reported to have a 95% success rate where preventing pregnancy is concerned.
'"/>




Page: 1

Related medicine news :

1. Tobacco industry legally sued by Manitoba and other provinces
2. Tuberculosis Outbreak In Manitoba Reserve
3. India to Set Up Health Ombudsman to Check Anti-AIDS Discrimination
4. Paracetamol May Cause Live Damage Warns Consumer Education and Research Centre
5. Study Warns About The Use Of Popular Asthma Drug To Stop Childrens Coughs
6. ADB Report Warns of Bird-Flu Catastrophe
7. FDA Warns Against Birth-Control Patch
8. Charlotte Church Warns kiss n tell girls not to flirt with Henson
9. UK Committee Warns on Food Shortages Due to Flu Epidemic
10. NHS Audit Commission Warns Possible Financial Collapse In Sussex And Surrey
11. Bishop Warns Against Change in Mercy Killing Laws
Post Your Comments:
Breaking Medicine Technology:Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 2Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 3Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 4Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 5Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 6Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 4Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 5Despite Limited Capital Equipment Purchases In 2009, The Global Powered Surgical Instrument Market Held Its Value At $800 Million 2Despite Limited Capital Equipment Purchases In 2009, The Global Powered Surgical Instrument Market Held Its Value At $800 Million 3ATS Medical Announces FDA Approval for a Landmark Clinical Investigation of the ATS 3f Aortic Bioprosthesis 4905 1ATS Medical Announces FDA Approval for a Landmark Clinical Investigation of the ATS 3f Aortic Bioprosthesis 4905 2ATS Medical Announces FDA Approval for a Landmark Clinical Investigation of the ATS 3f Aortic Bioprosthesis 4905 3Provocative New Fiction Makes for a Fascinating Fast Paced Read 13713 1Provocative New Fiction Makes for a Fascinating Fast Paced Read 13713 2LiveProcess Implements Emergency Management Platform with 51 Florida Hospitals 55482 1LiveProcess Implements Emergency Management Platform with 51 Florida Hospitals 55482 2